Ishaq Farhan, Guha Ashrith
Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist, Houston, Texas, US.
Methodist Debakey Cardiovasc J. 2025 May 15;21(3):5-12. doi: 10.14797/mdcvj.1579. eCollection 2025.
Heart transplantation is a marvel of modern medicine for patients with end-stage heart failure. Decades of research and surgical innovation have overcome challenges in immunology, organ preservation, and patient care. From the earliest heart transplants on canines and primates, the field evolved through immunosuppressive therapies, development of the bioptome for endomyocardial biopsy and, recently, the use of cell free DNA and molecular microscopy for assessing rejection. Newer developments in organ preservation systems and transport systems bring remarkable increases in the availability of donors.
心脏移植对于终末期心力衰竭患者而言是现代医学的一项奇迹。数十年的研究与外科创新克服了免疫学、器官保存及患者护理方面的挑战。从最早在犬类和灵长类动物身上进行心脏移植开始,该领域通过免疫抑制疗法、用于心内膜心肌活检的活检钳的研发,以及近来用于评估排斥反应的游离DNA和分子显微镜技术得以不断发展。器官保存系统和运输系统的新进展显著提高了供体的可获得性。